Latest news: Latest news from SONVY. - Fly (2023)

Hoy

show full stories

X

To see all the stories in an enlarged form, please register.

Get a free trial

Send information

recommendations

Son's price target lowered to CHF 253 from CHF 260 at Deutsche Bank» 15:06 sati

22/05/23

22/05

15:06 sati

22/05/23

15:06 sati

Sinc

Sonova

56,97 $ /

+1,5(+2,70%)

Analista de Deutsche Bank...

The story is temporarily locked.
To read stories as they happen, sign up, log in above, or come backMay 25 at 3:06 p.m.

Get a free trial

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
56,97 $ /

+1,5(+2,70%)

17/05/23 Barclays
Son's price target lowered to CHF 300 from CHF 315 at Barclays
17.05.23. swiss credit
Son's price target lowered to CHF 250 from CHF 260 on Credit Suisse
17/05/23 JPMorgan
Sonova was demoted to Neutral from Overweight at JPMorgan
12/05/23 Bernstein
Sonova started with Underperform at Bernstein
Wednesday

recommendations

Son's price target lowered to CHF 300 from CHF 315 at Barclays» 15:04 sati

17/05/23

17/05

15:04 sati

17/05/23

15:04 sati

Sinc

Sonova

55,46 $ /

-6,6616(-10,72%)

Hassan, an analyst at Barclays...

Barclays analyst Hassan Al-Wakeel cut the company's price target for Sonova to CHF 300 from CHF 315 and maintains an overweight rating for the stock.

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
55,46 $ /

-6,6616(-10,72%)

17.05.23. swiss credit
Son's price target lowered to CHF 250 from CHF 260 on Credit Suisse
17/05/23 JPMorgan
Sonova was demoted to Neutral from Overweight at JPMorgan
12/05/23 Bernstein
Sonova started with Underperform at Bernstein
04/03/23 Barclays
Son's price target lowered to CHF 315 from CHF 320 at Barclays

recommendations

Son's price target lowered to CHF 250 from CHF 260 on Credit Suisse» 14:53

17/05/23

17/05

14:53

17/05/23

14:53

Sinc

Sonova

55,46 $ /

-6,6616(-10,72%)

Credit Suisse analyst...

Credit Suisse analyst Christoph Gretler lowered the company's price target for Sonova to CHF 250 from CHF 260 and maintains a neutral rating on the stock.

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
55,46 $ /

-6,6616(-10,72%)

17/05/23 JPMorgan
Sonova was demoted to Neutral from Overweight at JPMorgan
12/05/23 Bernstein
Sonova started with Underperform at Bernstein
04/03/23 Barclays
Son's price target lowered to CHF 315 from CHF 320 at Barclays
04/03/23 JPMorgan
Son's price target raised to CHF 290 from CHF 281 at JPMorgan

Downhill

Sonova was demoted to Neutral from Overweight at JPMorgan» 04:34

17/05/23

17/05

04:34

17/05/23

04:34

Sinc

Sonova

55,46 $ /

-6,6616(-10,72%)

JPMorgan analyst David...

JPMorgan analyst David Adlington has downgraded Sonova's rating to Neutral from Overweight with a CHF 283 price target, from CHF 290. The analyst sees limited upside potential for earnings and the company's valuation after performance of the company in the second half "was a little lower than expected".

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
55,46 $ /

-6,6616(-10,72%)

12/05/23 Bernstein
Sonova started with Underperform at Bernstein
04/03/23 Barclays
Son's price target lowered to CHF 315 from CHF 320 at Barclays
04/03/23 JPMorgan
Son's price target raised to CHF 290 from CHF 281 at JPMorgan
25/01/23 Jefferies
Buying into Jefferies reduced Sonova to underperformance
More than a week ago

Beginning

Sonova started with Underperform at Bernstein» 04:49

12/05/23

05/12

04:49

12/05/23

04:49

Sinc

Sonova

63,49 $ /

-0,07(-0,11%)

Analyst Bernstein…

Bernstein analyst Susannah Ludwig started coverage of Sonova with an underperform rating and a CHF 235 price target. The analyst launched coverage for hearing and dental products, saying limited insurance and easily delayed procedures they are pushing treatments to compete in discretionary markets. Products are more cyclical, but low penetration leaves a theoretical opportunity of $30 billion in hearing and $100 billion in specialty dentistry, the analyst told investors in a research note. Structurally, the company favors dental markets and listen, Bernstein says, it's all about "picking relative winners."

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
63,49 $ /

-0,07(-0,11%)

04/03/23 Barclays
Son's price target lowered to CHF 315 from CHF 320 at Barclays
04/03/23 JPMorgan
Son's price target raised to CHF 290 from CHF 281 at JPMorgan
25/01/23 Jefferies
Buying into Jefferies reduced Sonova to underperformance
12/01/23 Morgan Stanley
Son's price target lowered to CHF 250 from CHF 260 at Morgan Stanley
More than a month ago

recommendations

Son's price target lowered to CHF 315 from CHF 320 at Barclays» 15:54

03.04.23

04/03

15:54

03.04.23

15:54

Sinc

Sonova

58,75 $ /

+0,54(+0,93%)

Hassan, an analyst at Barclays...

Barclays analyst Hassan Al-Wakeel cut the company's price target for Sonova to CHF 315 from CHF 320 and maintains an overweight rating on the stock.

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
58,75 $ /

+0,54(+0,93%)

04/03/23 JPMorgan
Son's price target raised to CHF 290 from CHF 281 at JPMorgan
25/01/23 Jefferies
Buying into Jefferies reduced Sonova to underperformance
12/01/23 Morgan Stanley
Son's price target lowered to CHF 250 from CHF 260 at Morgan Stanley
12/12/22 Graduated
Sonova began selling to Citi

recommendations

Son's price target raised to CHF 290 from CHF 281 at JPMorgan» 15:01 sati

03.04.23

04/03

15:01 sati

03.04.23

15:01 sati

Sinc

Sonova

58,75 $ /

+0,54(+0,93%)

JPMorgan has raised...

JPMorgan raised the company's target price for Sonova to CHF 290 from CHF 281 and maintains an Overweight rating on the stock.

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
58,75 $ /

+0,54(+0,93%)

25/01/23 Jefferies
Buying into Jefferies reduced Sonova to underperformance
12/01/23 Morgan Stanley
Son's price target lowered to CHF 250 from CHF 260 at Morgan Stanley
12/12/22 Graduated
Sonova began selling to Citi
22/11/22 Barclays
Son's price target raised to CHF 330 from CHF 290 at Barclays
more than a quarter ago

Downhill

Buying into Jefferies reduced Sonova to underperformance» 04:51

25/01/23

25/01

04:51

25/01/23

04:51

Sinc

Sonova

50,58 $ /

+0,54(+1,08%)

Michael, Jefferies analyst...

Jefferies analyst Michael Toomey doubled Sonova to Underperform from Buy with a CHF 200 price target, from CHF 340. Consensus expectations do not explain Costco KS contract loss and "moderate" market growth in the second half of fiscal years 2023 and 2024, the analyst told investors in a research note.

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
50,58 $ /

+0,54(+1,08%)

12/01/23 Morgan Stanley
Son's price target lowered to CHF 250 from CHF 260 at Morgan Stanley
12/12/22 Graduated
Sonova began selling to Citi
22/11/22 Barclays
Son's price target raised to CHF 330 from CHF 290 at Barclays
11/15/22 JPMorgan
Son's price target lowered to CHF 281 from CHF 313 at JPMorgan

recommendations

Son's price target lowered to CHF 250 from CHF 260 at Morgan Stanley» 15:33

01/12/23

01/12

15:33

01/12/23

15:33

Sinc

Sonova

49,74 $ /

-0,058(-0,12%)

Morgan Stanley analyst...

Morgan Stanley analyst Robert Davis cut the company's price target for Sonova to CHF 250 from CHF 260 and maintains an equal weight rating on the shares.

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
49,74 $ /

-0,058(-0,12%)

12/12/22 Graduated
Sonova began selling to Citi
22/11/22 Barclays
Son's price target raised to CHF 330 from CHF 290 at Barclays
11/15/22 JPMorgan
Son's price target lowered to CHF 281 from CHF 313 at JPMorgan
18/10/22 Morgan Stanley
Sonova started out as an equal weight at Morgan Stanley

Beginning

Sonova began selling to Citi» 06:13

12.12.22

12/12

06:13

12.12.22

06:13

Sinc

Sonova

52,34 $ /

+0,6405(+1,24%)

Veronika, analyst de Citija...

Citi analyst Veronika Dubajova initiated coverage of Sonova with a put rating and a CHF 220 price target. Below-average revenue and earnings growth is expected for the European healthcare services and medtech group in 2023, with slightly improved surgical volumes offset by consumer confidence and above-average wage growth, Dubai told investors in a research note. However, the analyst expects the industry to post revenue and earnings growth "well above" Citi strategists' market expectations. Dubajova favors "qualitative growth resistant to macroeconomic headwinds," or where she sees significant sources of growth in the medium term.

projectionTo hideRelated things>><<

  • street investigation
Sinc Sonova
52,34 $ /

+0,6405(+1,24%)

22/11/22 Barclays
Son's price target raised to CHF 330 from CHF 290 at Barclays
11/15/22 JPMorgan
Son's price target lowered to CHF 281 from CHF 313 at JPMorgan
18/10/22 Morgan Stanley
Sonova started out as an equal weight at Morgan Stanley
18/10/22 Deutsche Bank
Son's price target lowered to CHF 260 from CHF 291 at Deutsche Bank

Videos

1. ⭐ Sony A84L vs LG C3, BenQ 4K Projector Reviews, Munich Show, Special Guest from the PVA + AV news
(AVForums)
2. Saudi Arabia Latest Flight News | Very BigNews For All New Visa And Iqama Holders | KSA Flight News
(Saudi Breaking News)
3. Why Are These Fish Beaching Themselves? | BBC Earth
(BBC Earth)
4. I use the Nikon Z8.
(Omar Gonzalez Photography)
5. McGregor vs. Chandler 🍿
(ESPN MMA)
6. Arctic Geese Chicks Jump Off Cliff to Survive | Hostile Planet
(National Geographic)
Top Articles
Latest Posts
Article information

Author: Roderick King

Last Updated: 04/05/2023

Views: 6335

Rating: 4 / 5 (71 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Roderick King

Birthday: 1997-10-09

Address: 3782 Madge Knoll, East Dudley, MA 63913

Phone: +2521695290067

Job: Customer Sales Coordinator

Hobby: Gunsmithing, Embroidery, Parkour, Kitesurfing, Rock climbing, Sand art, Beekeeping

Introduction: My name is Roderick King, I am a cute, splendid, excited, perfect, gentle, funny, vivacious person who loves writing and wants to share my knowledge and understanding with you.